| |
| |
|
| Insider
Information: |
Vagelos P Roy |
| Relationship: |
Director |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
717,380 |
|
|
Indirect Shares
|
1,322,453 |
|
|
| Direct
Value |
$305,903,965 |
|
|
|
Indirect Value
|
$166,179,277 |
|
|
| Total
Shares |
2,039,833 |
|
|
| Total
Value |
$472,083,242 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2023-04-03 |
312,578 |
2023-04-03 |
154,526 |
Premium* |
|
|
Innoviva Inc |
INVA |
Director |
2009-12-23 |
404,802 |
2009-12-23 |
1,167,927 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-04-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
259 |
125,493 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-03-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
25,000 |
312,578 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-22 |
4 |
D |
$750.16 |
$21,758,391 |
D/D |
(29,005) |
337,578 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-02-22 |
4 |
OE |
$270.43 |
$11,493,275 |
D/D |
42,500 |
366,583 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2023-01-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
291 |
125,752 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-20 |
4 |
D |
$728.86 |
$102,864 |
I/I |
(141) |
1,961 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,651 |
324,083 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-12-09 |
4 |
D |
$753.28 |
$42,937 |
D/D |
(57) |
322,432 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-10-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
304 |
126,043 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-07-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
357 |
126,347 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-05-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
23,077 |
322,489 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-04-06 |
4 |
GD |
$0.00 |
$0 |
I/I |
302 |
126,704 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-30 |
4 |
AS |
$700.00 |
$20,000,686 |
I/I |
(28,572) |
23,461 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-14 |
4 |
D |
$655.29 |
$31,521,415 |
D/D |
(48,103) |
345,566 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-03-14 |
4 |
OE |
$179.13 |
$13,434,750 |
D/D |
75,000 |
393,669 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2022-01-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
338 |
141,292 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-12-16 |
4 |
D |
$634.70 |
$80,008 |
I/I |
(126) |
2,095 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,861 |
318,669 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-10-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
347 |
141,630 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-25 |
4 |
D |
$667.39 |
$32,890,314 |
D/D |
(49,282) |
316,808 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-25 |
4 |
OE |
$179.13 |
$13,434,750 |
D/D |
75,000 |
366,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-18 |
4 |
AS |
$650.04 |
$6,525,752 |
I/I |
(10,039) |
37,747 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
17,000 |
291,090 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-07-02 |
4 |
GD |
$0.00 |
$0 |
I/I |
373 |
141,977 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-06-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
19,000 |
308,090 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
